Absence of histological changes after the administration of a continuous intrathecal clonidine in wistar rats

Pain Practice

Volumn 9, Issue 2, 2009, Pages 122-129

  Guevara lópez, Uriah ^a,b   Aldrete, J Antonio ^c,d   Covarrubias gómez, Alfredo ^a   Hernández pando, Rogelio E ^a   López muñoz, Francisco J ^e  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d Arachnoiditis Foundation Inc   (United States)

^e Cinvestav Sede sur   (Mexico)

Author keywords

Clonidine; Continuous infusion; Intrathecal; Neurotoxic; Rodent model

Indexed keywords

CLONIDINE; PLACEBO; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHRONIC PAIN; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG SAFETY; HISTOPATHOLOGY; INTRACTABLE PAIN; MALE; MICROSCOPY; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; OSMOTIC PUMP; RAT; SPINAL CORD; TREATMENT DURATION; WISTAR RAT;

ANALGESICS; ANIMALS; CLONIDINE; DRUG ADMINISTRATION SCHEDULE; GLIOSIS; INJECTIONS, SPINAL; MALE; MYELIN SHEATH; NEUROTOXICITY SYNDROMES; RATS; RATS, WISTAR; SPINAL CORD; STATISTICS AS TOPIC;

EID: 61549104607     PISSN: 15307085     EISSN: 15332500     Source Type: Journal    
DOI: 10.1111/j.1533-2500.2008.00251.x     Document Type: Article

References (46)

1. Wilson PR, Yaksh TL. Pharmacology of pain and analgesia. Anaesth Intensive Care. 1980; 8: 248-256.
2. Kitahata LM, Collins JG. Spinal action of narcotic analgesics. Anesthesiology. 1981; 54: 153-163.
3. Yaksh TL. Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing. Pharmacol Biochem Behav. 1985; 22: 845-858.
4. Sosnowski M, Yaksh TL. Spinal administration of receptor-selective drugs as analgesics: New horizons. J Pain Symptom Manage. 1990; 5: 204-213.
5. Hodgson PS, Neal JM, Pollock JE, Liu SS. The neurotoxicity of drugs given intrathecally (spinal). Anesth Analg. 1999; 88: 797-809.
6. Aldrete JA. Neurologic deficits and arachnoiditis following neuroaxial anesthesia. Acta Anaesthesiol Scand. 2003; 47: 3-12.
7. Hassenbusch SJ, Portenoy RK, Cousins M, et al. Consensus Conference 2003: An update on the management of pain by intraspinal drug delivery: report of an expert panel. J Pain Symptom Manage. 2004; 27: 540-563.
8. Hassenbusch SJ, Portenoy RK, Cousins M, et al. Consensus Conference 2003: An update on the management of pain by intraspinal drug delivery-report of an expert panel. J Pain Symptom Manage. 2004; 27: 540-563.
9. Paech MJ, Pavy TJ, Orlikowski CE, et al. Postcesarean analgesia with spinal morphine, clonidine, or their combination. Anesth Analg. 2004; 98: 1460-1466.
10. Sites BD, Beach M, Biggs R, et al. Intrathecal clonidine added to a bupivacaine-morphine spinal anesthetic improves postoperative analgesia for total knee arthouroplasty. Anesth Analg. 2003; 96: 1083-1088.
11. Dobrydnjov I, Axelsson K, Gupta A, Lundin A, Holmstrom B, Granath B. Improved analgesia with clonidine when added to local anesthetic during combined spinal-epidural anesthesia for hip arthouroplasty: A double-blind, randomized and placebo-controlled study. Acta Anaesthesiol Scand. 2005; 49: 538-545.
12. Davis BR, Kopacz DJ. Spinal 2-chloroprocaine: The effect of added clonidine. Anesth Analg. 2005; 100: 559-565.
13. Kanazi GE, Aouad MT, Jabbour-Khoury SI, et al. Effect of low-dose dexmedetomidine or clonidine on the characteristics of bupivacaine spinal block. Acta Anaesthesiol Scand. 2006; 50: 222-227.
14. Eisenach JC, DuPen S, Dubois M, Miguel R, Allin D. Epidural clonidine analgesia for intractable cancer pain. The Epidural Clonidine Study Group. Pain. 1995; 61: 391-399.
15. Rauck RL, Eisenach JC, Jackson K, Young LD, Southern J. Epidural clonidine treatment for refractory reflex sympathetic dystrophy. Anesthesiology. 1993; 79: 1163-1169.
16. Perren F, Buchser E, Chedel D, Hirt L, Maeder P, Vingerhoets F. Spinal cord lesion after long-term intrathecal clonidine and bupivacaine treatment for the management of intractable pain. Pain. 2004; 109: 189-194.
17. Siddall PJ, Molloy AR, Walker S, Mather LE, Rutkowski SB, Cousins MJ. The efficacy of intrathecal morphine and clonidine in the treatment of pain after spinal cord injury. Anesth Analg. 2000; 91: 1493-1498.
18. Pan HL, Chen SR, Eisenach JC. Role of spinal NO in antiallodynic effect of intrathecal clonidine in neuropathic rats. Anesthesiology. 1998; 89: 1518-1523.
19. Aronov S, Ben-Abraham R, Givati-Divshi D, Katz Y. Involvement of nitric oxide in clonidine-induced spinal analgesia. Drug Metabol Drug Interact. 2005; 21: 41-53.
20. Duflo F, Conklin D, Li X, Eisenach JC. Spinal adrenergic and cholinergic receptor interactions activated by clonidine in postincisional pain. Anesthesiology. 2003; 98: 1237-1242.
21. Obata H, Li X, Eisenach JC. Alpha2-Adrenoceptor activation by clonidine enhances stimulation-evoked acetylcholine release from spinal cord tissue after nerve ligation in rats. Anesthesiology. 2005; 102: 657-662.
22. Gordh TE, Ekman S, Lagerstedt AS. Evaluation of possible spinal neurotoxicity of clonidine. Ups J Med Sci. 1984; 89: 266-273.
23. Gordh T Jr, Post C, Olsson Y. Evaluation of the toxicity of intrathecal clonidine, guanfacine, and a substance P-antagonist on rat spinal cord and nerve roots: Light and electron microscopic observations after chronic intrathecal administration. Anesth Analg. 1986; 65: 1303-1311.
24. Yaksh TL, Rathbun M, Jage J, Mirzai T, Grafe M, Hiles RA. Pharmacology and toxicology of chronically infused epidural clonidine HCl in dogs. Fundam Appl Toxicol. 1994; 23: 319-335.
25. Plummer JL, Cmielewski PL, Tallents S, etal. Development of tolerance to antinociceptive effects of an intrathecal morphine/clonidine combination in rats. Naunyn Schmiedebergs Arch Pharmacol. 1995; 351: 618-623.
26. Kroin JS, McCarthy RJ, Penn RD, Lubenow TJ, Ivankovich AD. Continuous intrathecal clonidine and tizanidine in conscious dogs: Analgesic and hemodynamic effects. Anesth Analg. 2003; 96: 776-782.
27. Rowlingson JC. Toxicity of local anesthetic additives. Reg Anesth. 1993; 18: 453-460.
28. Covino BG, Dubner R, Gybels J, et al. Ethical standards for investigations of experimental pain in animals. Pain. 1980; 9: 141-143.
29. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 1983; 16: 109-110.
30. Yaksh TL, Rudy TA. Chronic catheterization of the spinal intrathecal space. Physiol Behav. 1976; 17: 1031-1036.
31. Perren F, Buchser E, Chédel D, Hirt L, Maeder P, Vingerhoets F. Spinal cord lesion after long-term intrathecal clonidine and bupivacaine treatment for the management of intractable pain. Pain. 2004; 109: 189-194.
32. Stearns L, Boortz-Marx R, Du Pen S, et al. Intrathecal drug delivery for the management of cancer pain: A multidisciplinary consensus of best clinical practices. J Support Oncol. 2005; 3: 399-408.
33. Bennett G, Burchiel K, Buchser E, et al. Clinical guidelines for intraspinal infusion: Report of an expert panel. PolyAnalgesic Consensus Conference 2000. J Pain Symptom Manage. 2000; 20: S37-S43.
34. Bevacqua BK, Fattouh M, Backonja M. Depression, night terrors, and insomnia associated with long-term intrathecal clonidine therapy. Pain Pract. 2007; 7: 36-38.
35. Crosby G, Russo MA, Szabo MD, Davies KR. Subarachnoid clonidine reduces spinal cord blood flow and glucose utilization in conscious rats. Anesthesiology. 1990; 73: 1179-1185.
36. Godwin DA, Nae-Hwa K, Ziniga R. Stability of a baclofen and clonidine hydrochloride admixture for intrathecal administration. Hosp Pharm. 2001; 36: 950-954.
37. Classen AM, Wimbish GH, Kupiec TC. Stability of admixture containing morphine sulfate, bupivacaine hydrochloride, and clonidine hydrochloride in an implantable infusion system. J Pain Symptom Manage. 2004; 28: 603-611.
38. Rudich Z, Peng P, Dunn E, McCartney C. Stability of clonidine in clonidine-hydromorphone mixture from implanted intrathecal infusion pumps in chronic pain patients. J Pain Symptom Manage. 2004; 28: 599-602.
39. Hildebrand KR, Elsberry DD, Hassenbusch SJ. Stability and compatibility of morphine-clonidine admixtures in an implantable infusion system. J Pain Symptom Manage. 2003; 25: 464-471.
40. Wulf H, Gleim M, Mignat C. The stability of mixtures of morphine hydrochloride, bupivacaine hydrochloride, and clonidine hydrochloride in portable pump reservoirs for the management of chronic pain syndromes. J Pain Symptom Manage. 1994; 9: 308-311.
41. Guevara-López U, Aldrete JA, DeLille R, Gutierrez B. Evaluación de la neurotoxicidad de indometacina administrada en forma crónica en el espacio intratecal de ratas. Rev Soc Esp Dol. 2000; 7: 370-374.
42. Nishiyama T, Kawasaki-Yatsugi S, Yamaguchi T, Hanaoka K. Spinal neurotoxicity and tolerance after repeated intrathecal administration of YM 872, an AMPA receptor antagonist, in rats. J Anesth. 2004; 18: 113-117.
43. Guevara-López U, Covarrubias-Gómez A, Gutierrez-Acar H, Aldrete JA, López-Muñoz FJ, Martínez-Benítez B. Chronic intrathecal administration of 1-(4chlorobenzoyl)-5methoxy-2methyl-1H-indole-3 acetic acid (indomethacin): An evaluation of its neurotoxic effects in an animal model. Anesth Analg. 2006; 103: 99-102.
44. Pan HL, Chen SR, Eisenach JC. Intrathecal clonidine alleviates allodynia in neuropathic rats: Interaction with spinal muscarinic and nicotinic receptors. Anesthesiology. 1999; 90: 509-514.
45. Xu Z, Chen SR, Eisenach J, Pan HL. Role of spinal muscarinic and nicotinic receptors in clonidine-induced nitric oxide release in a rat model of neuropathic pain. Brain Res. 2000; 861: 390-398.
46. Eisenach JC, Dewan DM, Rose JC, Angelo JM. Epidural clonidine produces antinociception, but not hypotension, in sheep. Anesthesiology. 1987; 66: 496-501.